U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958341) titled 'Neuroimmunology Registry and Biobank' on April 14.
Brief Summary: A variety of antineuronal antibodies have been detected in the cerebrospinal fluid (CSF) of patients with neurological diseases. This raises the question of whether these antibodies are disease-specific or merely an epiphenomenon of inflammatory processes in the brain.
The registry was established with the following objectives: [1] Are antineuronal antibodies much more common than previously thought in various neurological disorders for which the etiology has not yet been elucidated? [2] Can further correlations, such as those between HSV infection and NMDA receptor au...